|
End-of-day quote
Nasdaq
2026-10-27
|
5-day change | 1st Jan Change | ||
| 8.890 USD | -3.47% |
|
-9.01% | -39.73% |
| 08-31 | Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-30 | Daxor Launches Blood Testing Lab in Eastern Kansis | MT |
Evolution of the Average Target: Daxor Corporation
Evolution of the Target Price: Daxor Corporation
Changes in Analyst Recommendations: Daxor Corporation
559edbe66c44fb5081d239.lRD_Egt-ko_YQ5Jfu15VQM9LFgcHrbHQCGZdqFFhvn8.xX2TQFIN-s6LMfhm3DkvJYglRVhsz4GBegEt-Bgy2zPWdLt9PRX0xL518Q~f3dea263ca1b60e7492f049d9506b098
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.970USD
Average target price
20.00USD
Spread / Average Target
+122.97%
High Price Target
22.00USD
Spread / Highest target
+145.26%
Low Price Target
18.00USD
Spread / Lowest Target
+100.67%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- DXR Stock
- Consensus Daxor Corporation
Select your edition
All financial news and data tailored to specific country editions
